Healthcare [ 12/13 ] | Medical Devices [ 134/159 ]
NASDAQ | Common Stock
Reported Date | EPSChange YoY | EstimateSurprise |
---|---|---|
Feb 14, 24 | -1.37 Decreased by -1.04 K% | -1.23 Decreased by -11.38% |
Nov 14, 23 | -1.22 Decreased by -577.78% | -1.4 Increased by +12.86% |
Aug 10, 23 | -0.14 Increased by +26.32% | -0.13 Decreased by -7.69% |
Jun 28, 23 | -0.1 Increased by +61.54% | -0.13 Increased by +23.08% |
Feb 13, 23 | -0.12 Increased by +25% | -0.08 Decreased by -50% |
Nov 14, 22 | -0.18 Decreased by -38.46% | -0.21 Increased by +14.29% |
Aug 9, 22 | -0.19 Decreased by -18.75% | -0.22 Increased by +13.64% |
Jun 28, 22 | -0.26 Decreased by -73.33% | -0.14 Decreased by -85.71% |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Dec 31, 23 | 0 Decreased by N/A% | -3.47 B Decreased by -124.96 K% | Decreased by N/A% Decreased by N/A% |
Sep 30, 23 | 0 Decreased by N/A% | -3.03 M Increased by +23.17% | Decreased by N/A% Decreased by N/A% |
Jun 30, 23 | 0 Decreased by N/A% | -3.28 M Decreased by -12.96% | Decreased by N/A% Decreased by N/A% |
Mar 31, 23 | 574.25 K Increased by +4.28 K% | -2.46 M Increased by +35.11% | Decreased by -427.69% Increased by +98.52% |
Dec 31, 22 | 0 Decreased by -100% | -2.77 M Decreased by -9.74% | Decreased by N/A% Decreased by N/A% |
Sep 30, 22 | 0 Decreased by -100% | -3.95 M Decreased by -96.69% | Decreased by N/A% Decreased by N/A% |
Jun 30, 22 | 0 Decreased by -100% | -2.91 M Decreased by -38.54% | Decreased by N/A% Decreased by N/A% |
Mar 31, 22 | 13.12 K Decreased by -61.69% | -3.79 M Decreased by -67.26% | Decreased by -28.86 K% Decreased by -336.56% |
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.